ARDS prevalence

View All

emerging-therapies-in-ards-market
Watch Out for the Most Promising Therapies in the Pipeline in ARDS Market

Acute respiratory distress syndrome (ARDS) is a rapidly progressing condition that affects critically ill people. The major complication of ARDS is fluid leaking into the lungs, which makes breathing difficult or impossible. Shortness of breath, cough, and fever are among ARDS symptoms; in certain cases, high heart...

Find More

ards-market-outlook
What Factors are Shaping the Trends in the ARDS Market?

Despite decades of research, treatment options are limited in the ARDS market. There are only a few treatments available in the ARDS market. The mainstay of management remains supportive care with mechanical ventilation. Other ARDS treatment options for patients include supplemental oxygen, prone positioning, the u...

Find More

driving-factors-for-ards-prevalence
Rising Acute Respiratory Distress Syndrome (ARDS) Prevalence Posing a Major Public Health Concern

The acute respiratory distress syndrome (ARDS) prevalence is increasing every year; it is estimated that in the United States alone, about 190K Americans are diagnosed with ARDS each year. Prior to the COVID-19 global pandemic, more than 700K individuals in the US and 2 million cases globally developed ARDS from tr...

Find More